SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 24, 2002
-----------------------------------------------------------------
EXEGENICS INC.
(Exact name of registrant as specified in its charter)
Delaware 333-26078 75-2402409
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
2110 Research Row
Dallas, Texas 75235
(Address of principal executive
offices including zip code)
(214) 358-2000
(Registrant's telephone number,
including area code)
N.A.
----
(Former name or former address, if changed since last report)
Item 5. Other Events.
On October 24, 2002, we issued a press release announcing that we
received approval from The Nasdaq Stock Market to transfer the listing of our
common stock from the Nasdaq National Market to the Nasdaq SmallCap Market
effective at the opening of trading on October 25, 2002. A copy of the press
release is filed as Exhibit 99.1 hereto and incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Description
99.1 Press Release dated October 24, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
EXEGENICS INC.
(Registrant)
Dated: October 24, 2002 By: /s/ Ronald L. Goode
---------------- ----------------------------------
Ronald L. Goode
President and Chief Executive Officer
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 Press Release dated October 24, 2002.